A phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in patients with JAK inhibitor-naive myelofibrosis and moderate thrombocytopenia (XPORT-MF-044) Meeting Abstract
| Authors: | Scandura, J. M.; Gerds, A. T.; Ritchie, E. K.; Wang, X.; Kye, S.; Rampal, R. K. |
| Abstract Title: | A phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in patients with JAK inhibitor-naive myelofibrosis and moderate thrombocytopenia (XPORT-MF-044) |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3211 |
| Language: | English |
| ACCESSION: | WOS:001159740303074 |
| DOI: | 10.1182/blood-2023-181720 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
